News & Events

Oct 29, 2025, 08:11 ET

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

frustration and a lack of medicines that can treat the disease systemically," said Thierry Passeron, M.D., Ph.D., professor and chair, Department of Dermatology, Université Côte d'Azur." Read more

Oct 28, 2025, 12:17 ET

News provided by: American Academy of Dermatology

As online skincare trends continue to capture the attention of tweens and teens (and major retailers roll out early holiday promotions), an AAD board-certified dermatologist offers guidance to help families cut through the hype, reminding parents that simple, age-appropriate products are the most safe and effective.

Skincare needs shift as children grow, according to Marisa Garshick, MD, FAAD, a board-certified dermatologist in New York City who is also the mother of tweens. Tweens benefit from learning the basics, like cleansing, moisturizing, and sun protection, while teens face new challenges from hormonal changes that can lead to acne and oily skin. Read more

Oct 28, 2025, 09:33 ET

In Partnership with the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD), CeraVe Mobilizes 9 Countries to Expand Access to Dermatological Care Worldwide. Read more

Oct 27, 2025, 08:00 ET

New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile

Results show 50.5% of adult psoriasis patients eligible for systemic therapy and 47.5% of dermatology providers would prefer oral treatment over topicals or injectables. Read more

UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active psoriatic arthritis (PsA), non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, and ankylosing spondylitis (AS). Read more